Skip to main content

Ritodrine Pregnancy and Breastfeeding Warnings

Brand names: Yutopar

Ritodrine Pregnancy Warnings

Ritodrine has been assigned to pregnancy category B by the FDA. Animal studies have failed to reveal evidence of fetotoxicity. There are no controlled data in human pregnancy. Neonatal hypoglycemia, tachycardia, and ileus have been reported. Rarely, ketoacidosis resulting in fetal death has been reported. Ritodrine is only recommended for use during pregnancy when benefit outweighs risk.

See references

Ritodrine Breastfeeding Warnings

There are no data on the excretion of ritodrine into human milk.

See references

See also

References for pregnancy information

  1. Product Information. Yutopar (ritodrine). Astra-Zeneca Pharmaceuticals. 2001;PROD.

References for breastfeeding information

  1. Product Information. Yutopar (ritodrine). Astra-Zeneca Pharmaceuticals. 2001;PROD.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer